Small_Cell_Lung_Cancer . La Enfermedad Siempre Empeora en la Mayoría de los Pacientes, a Pesar de Que al Principio el Tratamiento Estaba Destinado a Curarlos .

Phase II/III Trial of SUGEMALIMAB in LS-SCLC Post Concurrent or Sequential Chemoradiotherapy .

There Should Still Be a Lot More Treatment Choices For People With Limited-Stage Small-Cell Lung Cáncer ( LS-SCLC ) .

DEC 30 , 2023 .

The Standard Treatment For LS-SCLC is Platinum-Based Doublet Chemotherapy Given at The Same Time As Lung Radiation (cCRT) . Sequential Chemoradiotherapy (sCRT) is Also Commonly Used . However, The Disease Always Gets Worse in Most Patients, Even though The Treatment Was Meant To Cure Them At First . ...